NCT02885129

Brief Summary

The main objective is to assess the measurement characteristics (validity, reproducibility) and the invariance of EGOMAC scale in a population of consultants in diabetology, cardiology and rheumatology hospital and liberal and hospital oncology and Infectious disease, by following the evolution of patient compliance at D0 and D15. The second objective is to assess the sensitivity to change of scale EGOMAC following developments compliance 3 months.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
397

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jun 2014

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2014

Completed
2.2 years until next milestone

First Submitted

Initial submission to the registry

August 23, 2016

Completed
8 days until next milestone

First Posted

Study publicly available on registry

August 31, 2016

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2017

Completed
Last Updated

August 16, 2017

Status Verified

August 1, 2017

Enrollment Period

2.8 years

First QC Date

August 23, 2016

Last Update Submit

August 13, 2017

Conditions

Chronic Diseases

Outcome Measures

Primary Outcomes (2)

  • EGOMAC questionnaire

    baseline

  • Change in EGOMAC questionnaire

    15 days

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Population of consultants in diabetology, cardiology and rheumatology hospital and liberal and hospital oncology and Infectious disease

You may qualify if:

  • patient age of 18 years
  • from routine patient counseling
  • with at least one of these diseases : heart failure, hypertension, coronary disease, type 2 diabetes, osteoarthritis of the knee or hip, osteoporosis, inflammatory rheumatism (rheumatoid arthritis, spondyloarthropathy), cancer ( with only non-hormonal oral anti cancer treatments) and HIV.
  • patient can read the French language in order to complete the self -administered questionnaire
  • patient agreeing to participate in the study

You may not qualify if:

  • patient receiving no drug prescription or recommendation of lifestyle or diet (for example consultationpurely diagnostic ).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Central hospital

Nancy, 54000, France

Location

MeSH Terms

Conditions

Chronic Disease

Condition Hierarchy (Ancestors)

Disease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Francis GUILLEMIN, MD, PhD

    CHRU Nancy

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

August 23, 2016

First Posted

August 31, 2016

Study Start

June 1, 2014

Primary Completion

April 1, 2017

Study Completion

April 1, 2017

Last Updated

August 16, 2017

Record last verified: 2017-08

Data Sharing

IPD Sharing
Will share

open to partnership

Locations

FR(1)